Cardinal Health (CAH) Stock

Cardinal Health has introduced the latest version of the Kendall Compression Series, called the Kendall SCD SmartFlow Compression System, to help relieve pain caused by venous stasis.

Cardinal Health, Inc. (NYSE:CAH) will be participating in the UBS Global Healthcare Conference on November 12, 2024, at 11:00 AM ET. The company representatives include Matt Sims, Vice President of Investor Relations, and Aaron Alt, Chief Financial Officer. Kevin Caliendo from UBS will be hosting the call.

CAH has announced two important acquisitions to enhance its multi-specialty and at-home solutions sectors. These moves aim to improve their services and offerings.

This is a comparison of how Cardinal Health (CAH) and Adaptive Biotechnologies (ADPT) have done in relation to their industry this year.

Cardinal Health has announced its plans to acquire a majority stake in GI Alliance, a top gastroenterology management services organization, to boost its growth strategy in multiple specialties. Additionally, the company will acquire the Advanced Diabetes Supply Group, a major provider of diabetes supplies directly to patients, to support its at-Home Solutions growth strategy. Cardinal Health also revealed plans to hold an Investor Day in June 2025.

Dublin, Ohio, November 5, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) has announced that its Board of Directors has approved a quarterly dividend of $0.5056 per share from the Company's capital surplus. This dividend will be paid on January 15, 2025, to shareholders who are on record as of the end of business on January 2, 2025.

On Friday, Cardinal Health (CAH) shares reached a record high during the day after the healthcare products company reported results that exceeded expectations and improved its forecast, despite facing financial losses from the conclusion of a major contract.

In the first quarter of fiscal 2025, Cardinal Health saw strong growth in its Pharmaceutical and Specialty Solutions sectors. However, the expiration of the OptumRx contract negatively impacted sales.

Cardinal Health (CAH) reported quarterly earnings of $1.88 per share, which is higher than the Zacks Consensus Estimate of $1.64 per share. This is an increase compared to earnings of $1.73 per share from the same period last year.